EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
[HTML][HTML] Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model
Y Philippou, HT Sjoberg, E Murphy, S Alyacoubi… - British journal of …, 2020 - nature.com
Background Radiotherapy enhances innate and adaptive anti-tumour immunity. It is unclear
whether this effect may be harnessed by combining immunotherapy with radiotherapy …
whether this effect may be harnessed by combining immunotherapy with radiotherapy …
Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international …
AH Lebastchi, AK George, TJ Polascik, J Coleman… - European urology, 2020 - Elsevier
Background Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by
urologists and radiologists as an option for the management of localized prostate cancer …
urologists and radiologists as an option for the management of localized prostate cancer …
Targeting radiation-resistant prostate cancer stem cells by B7-H3 CAR T cells
Y Zhang, L He, A Sadagopan, T Ma, G Dotti… - Molecular cancer …, 2021 - AACR
Radiotherapy (RT) is a key treatment for prostate cancer. However, RT resistance can
contribute to treatment failure. Prostate cancer stem cells (PCSCs) are radioresistant. We …
contribute to treatment failure. Prostate cancer stem cells (PCSCs) are radioresistant. We …
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
Objective To assess treatment related changes in quality of life up to 15 years after
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …
Patient-reported outcomes following treatment of localised prostate cancer and their association with regret about treatment choices
Background Well-documented reports of patients' experiences with different treatments are
important for helping localised prostate cancer (LPC) patients choose among the available …
important for helping localised prostate cancer (LPC) patients choose among the available …
[HTML][HTML] Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience
Purpose Diagnosis and treatment of prostate cancer can generate many challenges which
impact on adjustment, so understanding the psychosocial factors which contribute to …
impact on adjustment, so understanding the psychosocial factors which contribute to …
Magnetic resonance-guided stereotactic radiotherapy for localized prostate cancer: final results on patient-reported outcomes of a prospective phase 2 study
SU Tetar, AME Bruynzeel, SS Oei, S Senan… - European Urology …, 2021 - Elsevier
Background The recent introduction of magnetic resonance-guided radiation therapy
(MRgRT) has allowed improved treatment planning and delivery of stereotactic body …
(MRgRT) has allowed improved treatment planning and delivery of stereotactic body …
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
JA Lane, JL Donovan, GJ Young, M Davis… - BJU …, 2022 - Wiley Online Library
Objective To investigate the functional and quality of life (QoL) outcomes of treatments for
localised prostate cancer and inform treatment decision‐making. Patients and Methods Men …
localised prostate cancer and inform treatment decision‐making. Patients and Methods Men …